about
Intravital imaging reveals new ancillary mechanisms co-opted by cancer cells to drive tumor progressionELF5 Drives Lung Metastasis in Luminal Breast Cancer through Recruitment of Gr1+ CD11b+ Myeloid-Derived Suppressor CellsThe dynamics of Rho GTPase signaling and implications for targeting cancer and the tumor microenvironment.MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinib.Three-dimensional cancer models mimic cell-matrix interactions in the tumour microenvironment.The tyrosine phosphatase PTPN14 (Pez) inhibits metastasis by altering protein trafficking.Monitoring the dynamics of Src activity in response to anti-invasive dasatinib treatment at a subcellular level using dual intravital imagingSerpinB2 regulates stromal remodelling and local invasion in pancreatic cancer.Intravital FRAP Imaging using an E-cadherin-GFP Mouse Reveals Disease- and Drug-Dependent Dynamic Regulation of Cell-Cell Junctions in Live Tissue.Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis.Three-dimensional organotypic matrices from alternative collagen sources as pre-clinical models for cell biology.'MCC' protein interacts with E-cadherin and β-catenin strengthening cell-cell adhesion of HCT116 colon cancer cells.A RhoA-FRET Biosensor Mouse for Intravital Imaging in Normal Tissue Homeostasis and Disease Contexts.Shedding new light on RhoA signalling as a drug target in vivo using a novel RhoA-FRET biosensor mouse.Regulation of Tbx22 during facial and palatal development.Expression and regulation of ANTXR1 in the chick embryo.Molecular mobility and activity in an intravital imaging setting - implications for cancer progression and targeting.Intravital Imaging to Monitor Therapeutic Response in Moving Hypoxic Regions Resistant to PI3K Pathway Targeting in Pancreatic Cancer.Removing physiological motion from intravital and clinical functional imaging dataCombating pancreatic cancer with PI3K pathway inhibitors in the era of personalised medicineROBO2 is a stroma suppressor gene in the pancreas and acts via TGF-β signallingTargeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancerFluids and their mechanics in tumour transit: shaping metastasisCAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecanFgfr1 conditional-knockout in neural crest cells induces heterotopic chondrogenesis and osteogenesis in mouse frontal bones
P50
Q26745311-596E60E6-D33E-4878-9BC2-292127F76860Q27345430-34E4C84D-A1ED-4344-9F50-49E5C9A46B6FQ36147572-7970ADE5-0466-4AFC-A523-DA43ED8AB1F0Q37487789-0CBD9D3C-5658-49B8-B74B-E484AA8B5975Q38218018-09CD1568-2E3F-4304-8979-34532CB0D1BAQ38908701-9A161574-6D2B-4364-A3F6-B720AF4EE2B3Q38931516-4B97A884-1AC6-4BDF-B9D0-F2D7DC4649B2Q41193853-BE946F2A-A5D6-45A4-88AB-3470C211C415Q42678959-82300C0E-3A4B-419A-9A0E-7BB4A78AB15CQ45987365-242B31CF-8812-4ADF-A5F8-B7015F885E43Q47134459-26AC1980-D503-402E-BE13-9E0C50A303C0Q47648692-2C0DCBD7-3780-4C1C-A342-C1C607476E63Q49600766-C57E16AB-12F2-453A-8A39-338BD200BC56Q49853441-D11B972D-69CB-46CB-A865-7C603CA82724Q51899755-BEF53524-3434-4167-BFB8-3C467EC3839BQ51919648-C8C884FF-1A9A-41B2-BE18-76CF9DBDFE0FQ52671180-1B29B464-3D12-4FF5-964C-111DFBE9D0A2Q55400356-3FA9C75D-C090-472F-B78A-CCAFE2268C09Q56809927-A22F4101-5DBB-4625-9EDE-D7FE9EC7D62BQ58610296-569E9E84-6512-4626-A83C-BBB41C119D7EQ59799161-2327991D-6A6C-4972-AF2A-4BC94227D637Q61135683-2F57C785-1162-43C4-94BC-CAAACEF4BDB0Q91526523-E1418AE9-F93E-4074-9AAF-8BDC9C6CE287Q92577654-353F3EE9-A726-4028-8FD0-7EF3FA585E52Q93381432-A5801B65-5C65-4B69-B304-91B3171EA2CE
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
David Herrmann
@ast
David Herrmann
@en
David Herrmann
@es
David Herrmann
@nl
David Herrmann
@sl
type
label
David Herrmann
@ast
David Herrmann
@en
David Herrmann
@es
David Herrmann
@nl
David Herrmann
@sl
prefLabel
David Herrmann
@ast
David Herrmann
@en
David Herrmann
@es
David Herrmann
@nl
David Herrmann
@sl
P106
P21
P31
P496
0000-0002-9514-7501